Splenic infarction associated with sorafenib use in a hepatocellular carcinoma patient

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 2

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

334

HTML

2471

Figures (1-3)

211

Sum=3016

Jan 14, 2011 (publication date) through Oct 2, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Gastroenterol. Jan 14, 2011; 17(2): 267-270
Published online Jan 14, 2011. doi: 10.3748/wjg.v17.i2.267

Full Size Figure Download Figure

Figure 2 Follow up abdominal computed tomography (1 mo). New hypodense lesion has developed in upper level of the spleen (arrow).

Citation: Kim SO, Han SY, Baek YH, Lee SW, Han JS, Kim BG, Cho JH, Nam KJ. Splenic infarction associated with sorafenib use in a hepatocellular carcinoma patient. World J Gastroenterol 2011; 17(2): 267-270
URL: https://www.wjgnet.com/1007-9327/full/v17/i2/267.htm
DOI: https://dx.doi.org/10.3748/wjg.v17.i2.267